Exposure to per- and polyfluoroalkyl substances leads to immunotoxicity: Epidemiological and toxicological evidence

[1]  A. Gohara.  Toxic Responses of the Immune System , 2020 .

[2]  Toxicological Profile for Perfluoroalkyls: Draft for Public Comment , 2018 .

[3]  Jun Zhang,et al.  Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study , 2018, Environmental Health.

[4]  I. Cousins,et al.  A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)? , 2017, Environmental science & technology.

[5]  E. Budtz-Jørgensen,et al.  Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years , 2017, Journal of immunotoxicology.

[6]  Yongchao Ge,et al.  Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults. , 2016, Environmental research.

[7]  E. Budtz-Jørgensen,et al.  Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates , 2016, Journal of immunotoxicology.

[8]  M. Buser,et al.  Perfluoroalkyl substances and food allergies in adolescents. , 2016, Environment international.

[9]  R. Luebke,et al.  Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment , 2016, Current protocols in toxicology.

[10]  H. Adami,et al.  A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans , 2016, Critical reviews in toxicology.

[11]  M. Wolff,et al.  Perfluoroalkyl and Polyfluoroalkyl Substances and Indicators of Immune Function in Children Aged 12 – 19 years: NHANES , 2015, Pediatric Research.

[12]  A. Levy,et al.  Prenatal exposure to phthalates, bisphenol A and perfluoroalkyl substances and cord blood levels of IgE, TSLP and IL-33. , 2015, Environmental research.

[13]  R. Vermeulen,et al.  Prenatal exposure to environmental chemical contaminants and asthma and eczema in school‐age children , 2015, Allergy.

[14]  K. Steenland,et al.  A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA) , 2015, Occupational and Environmental Medicine.

[15]  J. Siemiatycki,et al.  Occupational exposure to wood dust and risk of lung cancer in two population-based case–control studies in Montreal, Canada , 2015, Environmental Health.

[16]  M. Ryu,et al.  Chronic exposure to perfluorinated compounds: Impact on airway hyperresponsiveness and inflammation. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[17]  P. Grandjean,et al.  Autoantibodies associated with prenatal and childhood exposure to environmental chemicals in Faroese children. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  R. Hiatt,et al.  Perfluoroalkyl Chemicals and Asthma among Children 12–19 Years of Age: NHANES (1999–2008) , 2014, Environmental health perspectives.

[19]  A. Tamakoshi,et al.  Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood. , 2014, Environment international.

[20]  A. Calafat,et al.  Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  L. S. Haug,et al.  Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood , 2013, Journal of immunotoxicology.

[22]  K. Steenland,et al.  Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley , 2013, Environmental health perspectives.

[23]  V. Vetvicka,et al.  Reversal of perfluorooctanesulfonate-induced immunotoxicity by a glucan-resveratrol-vitamin C combination , 2013, Oriental Pharmacy and Experimental Medicine.

[24]  W. Liu,et al.  Serum Polyfluoroalkyl Concentrations, Asthma Outcomes, and Immunological Markers in a Case–Control Study of Taiwanese Children , 2013, Environmental health perspectives.

[25]  D. Keil,et al.  Current Status of Developmental Immunotoxicity , 2012, Toxicologic pathology.

[26]  Esben Budtz-Jørgensen,et al.  Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. , 2012, JAMA.

[27]  T. Fletcher,et al.  The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. , 2011, Environmental research.

[28]  Yi-he Jin,et al.  Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice , 2011, Archives of Toxicology.

[29]  J. Depierre,et al.  28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: Does the route of administration play a pivotal role in PFOS-I , 2010 .

[30]  Yi-he Jin,et al.  Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice , 2009, Archives of Toxicology.

[31]  R. Luebke,et al.  Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  Yi-he Jin,et al.  Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice , 2009, Archives of Toxicology.

[33]  R. Mehta,et al.  Immunomodulatory Effects of Dietary Potassium Perfluorooctane Sulfonate (PFOS) Exposure in Adult Sprague-Dawley Rats , 2008, Journal of toxicology and environmental health. Part A.

[34]  S. Frame,et al.  Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  J. M. Keller,et al.  Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  J. Kotlerman,et al.  Self-Reported Health Effects among Community Residents Exposed to Perfluorooctanoate , 2008, New solutions : a journal of environmental and occupational health policy : NS.

[37]  D. Keil,et al.  Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  Mark J. Strynar,et al.  Perfluorooctanoic Acid–Induced Immunomodulation in Adult C57BL/6J or C57BL/6N Female Mice , 2008, Environmental health perspectives.

[39]  R. Luebke,et al.  Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment , 2004, Current protocols in toxicology.

[40]  R. Luebke,et al.  Suppression of Immune Function and Susceptibility to Infections in Humans: Association of Immune Function with Clinical Disease , 2004, Journal of immunotoxicology.

[41]  Qian Yang,et al.  Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. , 2002, International immunopharmacology.

[42]  Qiang Yang,et al.  Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. , 2001, Biochemical pharmacology.

[43]  J. Depierre,et al.  Effects of peroxisome proliferators on the thymus and spleen of mice , 2000, Clinical and experimental immunology.

[44]  M. Luster.  Immunotoxicology: Clinical Consequences , 1996, Toxicology and industrial health.

[45]  C. Gennings,et al.  Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[46]  S. Anderson,et al.  Investigative Immunotoxicology. , 2018, Methods in molecular biology.

[47]  M. Ward,et al.  Evaluating Antigen-Specific IgE Using the Rat Basophil Leukemia Cell (RBL) Assay. , 2018, Methods in molecular biology.

[48]  Tine K. Jensena,et al.  University of Southern Denmark Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination Timmermann, , 2018 .

[49]  G. Ladics.  The Sheep Erythrocyte T-Dependent Antibody Response (TDAR). , 2018, Methods in molecular biology.

[50]  Y. Saijo,et al.  Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants. , 2012, Environmental research.

[51]  K. White,et al.  The sheep erythrocyte T-dependent antibody response (TDAR). , 2010, Methods in molecular biology.

[52]  M. Selgrade.  Immunotoxicity: the risk is real. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  S. Anderson,et al.  Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.